Testing effectiveness (Phase 2)Looking for participantsNCT06524635
What this trial is testing
Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab
Who this might be right for
Hidradenitis SuppurativaAtopic Dermatitis
AbbVie 60